Rallybio Corp. (RLYB)
8.22
-0.22
(-2.61%)
USD |
NASDAQ |
Mar 27, 16:00
8.17
-0.05
(-0.61%)
After-Hours: 20:00
Rallybio EPS Diluted (Quarterly) : -1.108 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Talkspace, Inc. | 0.0277 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.852M |
| Revenue (Quarterly) | 0.222M |
| Total Expenses (Quarterly) | 6.074M |
| Enterprise Value | -11.15M |
| Gross Profit Margin (Quarterly) | 98.65% |
| Profit Margin (Quarterly) | -2.64K% |
| Earnings Yield | -2.50% |
| Normalized Earnings Yield | 2.647 |